|
1
|
Dik EA, Willems SM, Ipenburg NA, Rosenberg
AJ, Van Cann EM and van Es RJ: Watchful waiting of the neck in
early stage oral cancer is unfavourable for patients with occult
nodal disease. Int J Oral Maxillofac Surg. 45:945–950. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kolokythas A, Park S, Schlieve T, Pytynia
K and Cox D: Squamous cell carcinoma of the oral tongue:
Histopathological parameters associated with outcome. Int J Oral
Maxillofac Surg. 44:1069–1074. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhartiya D, Kumar A, Singh H, Sharma A,
Kaushik A, Kumari S and Mehrotra R: OrCanome: A comprehensive
resource for oral cancer. Asian Pac J Cancer Prev. 17:1333–1336.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong WM, Parvathaneni U, Jewell PD,
Martins RG, Futran ND, Laramore GE and Liao JJ: Squamous cell
carcinoma of the oral tongue in a patient with Fanconi anemia
treated with radiotherapy and concurrent cetuximab: A case report
and review of the literature. Head Neck. 35:E292–298.
2013.PubMed/NCBI
|
|
5
|
Amichetti M: Squamous cell carcinoma of
the oral tongue in patients less than fifteen years of age. Report
of a case and review of the literature. J Craniomaxillofac Surg.
17:75–77. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martínez C, Hernández M, Martínez B and
Adorno D: Frequency of oral squamous cell carcinoma and oral
epithelial dysplasia in oral and oropharyngeal mucosa in Chile. Rev
Med Chil. 144:169–174. 2016.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shrestha A, Marla V, Shrestha S and
Agrawal D: Awareness of undergraduate dental and medical students
towards oral cancer. J Cancer Educ. Mar 28–2016.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsumoto K, Sasaki T, Shioyama Y,
Nakamura K, Atsumi K, Nonoshita T, Ooga S, Yoshitake T, Uehara S,
Hirata H and Honda H: Treatment outcome of high-dose-rate
interstitial radiation therapy for patients with stage I and II
mobile tongue cancer. Jpn J Clin Oncol. 43:1012–1017. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirota K, Wakisaka N, Sawada-Kitamura S,
Kondo S, Endo K, Tsuji A, Murono S and Yoshizaki T:
Lymphangiogenesis in regional lymph nodes predicts nodal recurrence
in pathological N0 squamous cell carcinoma of the tongue.
Histopathology. 61:1065–1071. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mehrotra R and Yadav S: Oral squamous cell
carcinoma: Etiology, pathogenesis and prognostic value of genomic
alterations. Indian J Cancer. 43:60–66. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yates TJ, Knapp J, Gosalbez M, Lokeshwar
SD, Gomez CS, Benitez A, Ekwenna OO, Young EE, Manoharan M and
Lokeshwar VB: C-X-C chemokine receptor 7: A functionally associated
molecular marker for bladder cancer. Cancer. 119:61–71. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Fu W, Zhang S, He X, Liu Z, Gao D
and Xu T: CXCR-7 receptor promotes SDF-1α-induced migration of bone
marrow mesenchymal stem cells in the transient cerebral
ischemia/reperfusion rat hippocampus. Brain Res. 1575:78–86. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Shiozawa Y, Wang J, Wang Y, Jung
Y, Pienta KJ, Mehra R, Loberg R and Taichman RS: The role of
CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate
cancer. J Biol Chem. 283:4283–4294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang T, Xia QJ, Qiao X and Xi M:
Expression of C-X-C chemokine receptor type 7 in
otorhinolaryngologic neoplasms. Singapore Med J. 57:157–160. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma Y, Liu H, Zhang H and Shao RG: The
TGF-β signaling pathway induced EMT in breast cancer. Yao Xue Xue
Bao. 50:385–392. 2015.(In Chinese). PubMed/NCBI
|
|
16
|
Elsum IA, Martin C and Humbert PO:
Scribble regulates an EMT polarity pathway through modulation of
MAPK-ERK signaling to mediate junction formation. J Cell Sci.
126:3990–3999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gu K, Li MM, Shen J, Liu F, Cao JY, Jin S
and Yu Y: Interleukin-17-induced EMT promotes lung cancer cell
migration and invasion via NF-κB/ZEB1 signal pathway. Am J Cancer
Res. 5:1169–1179. 2015.PubMed/NCBI
|
|
18
|
David CJ, Huang YH, Chen M, Su J, Zou Y,
Bardeesy N, Iacobuzio-Donahue CA and Massagué J: TGF-β tumor
suppression through a lethal EMT. Cell. 164:1015–1030. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Attramadal CG, Kumar S, Boysen ME, Dhakal
HP, Nesland JM and Bryne M: Tumor budding, EMT and cancer stem
cells in T1-2/N0 oral squamous cell carcinomas. Anticancer Res.
35:6111–6120. 2015.PubMed/NCBI
|
|
20
|
Li Y, Ma J, Qian X, Wu Q, Xia J, Miele L,
Sarkar FH and Wang Z: Regulation of EMT by notch signaling pathway
in tumor progression. Curr Cancer Drug Targets. 13:957–962. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mitra A, Mishra L and Li S: EMT, CTCs and
CSCs in tumor relapse and drug-resistance. Oncotarget.
6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sawicka D, Chojnacka-Puchta L, Zielinski
M, Plucienniczak G, Plucienniczak A and Bednarczyk M: Flow
cytometric analysis of apoptosis in cryoconserved chicken
primordial germ cells. Cell Mol Biol Lett. 20:143–159. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pouessel D, Neuzillet Y, Mertens LS, Van
Der Heijden MS, de Jong J, Sanders J, Peters D, Leroy K, Manceau A
and Maille P: Tumor heterogeneity of fibroblast growth factor
receptor 3 (FGFR3) mutations in invasive bladder cancer:
Implications for perioperative anti-FGFR3 treatment. Ann Oncol.
27:1311–1316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Allegra M, Zaragkoulias A, Vorgia E,
Ioannou M, Litos G, Beug H and Mavrothalassitis G: Semaphorin-7a
reverses the ERF-induced inhibition of EMT in ras-dependent mouse
mammary epithelial cells. Mol Biol Cell. 23:3873–3881. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goepfert RP, Kezirian EJ and Wang SJ: Oral
tongue squamous cell carcinoma in young women: A matched
comparison-do outcomes justify treatment intensity? ISRN
otolaryngol 2014. 5293952014.
|
|
27
|
Fan KH, Lin CY, Kang CJ, Huang SF, Wang
HM, Chen EY, Chen IH, Liao CT, Cheng AJ and Chang JT:
Combined-modality treatment for advanced oral tongue squamous cell
carcinoma. Int J Radiat Oncol Biol Phys. 67:453–461. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lim YC, Lee JS, Koo BS, Kim SH, Kim YH and
Choi EC: Treatment of contralateral N0 neck in early squamous cell
carcinoma of the oral tongue: Elective neck dissection versus
observation. Laryngoscope. 116:461–465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schiff BA, Roberts DB, El-Naggar A, Garden
AS and Myers JN: Selective vs modified radical neck dissection and
postoperative radiotherapy vs observation in the treatment of
squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head
Neck Surg. 131:874–878. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abu-Serriah M, Shah KA, Rajamanohara R,
Fasanmade A, Graystone J, Gerry S and Bond S: Tumour depth of
invasion of pT1 squamous cell carcinoma of the oral tongue and risk
of pathologically detected neck metastases. Head Neck. Jun
3–2015.(Epub ahead of print). PubMed/NCBI
|
|
31
|
Helal HH, Qi CE, Zhao YY, Yao CS and Li de
C: The effects of combination of gefitinib and cisplatin on tongue
squamous cell carcinoma cell lines. J Cancer Res Ther. 11:37–40.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vandercappellen J, Van Damme J and Struyf
S: The role of CXC chemokines and their receptors in cancer. Cancer
Lett. 267:226–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bernatoniene J, Zhang Q, Dogan S, Mitchell
TJ, Paton JC and Finn A: Induction of CC and CXC chemokines in
human antigen-presenting dendritic cells by the pneumococcal
proteins pneumolysin and CbpA, and the role played by toll-like
receptor 4, NF-kappaB, and mitogen-activated protein kinases. J
Infect Dis. 198:1823–1833. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maksym RB, Tarnowski M, Grymula K,
Tarnowska J, Wysoczynski M, Liu R, Czerny B, Ratajczak J, Kucia M
and Ratajczak MZ: The role of stromal-derived factor-1-CXCR7 axis
in development and cancer. Eur J Pharmacol. 625:31–40. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shakeel Uz Zaman, Adeel M and Suhail A:
Squamous cell carcinoma of oral tongue in young patients-A 10 years
tertiary care experience. J Pak Med Assoc. 66:155–158.
2016.PubMed/NCBI
|
|
36
|
Zheng M, Jiang YP, Chen W, Li KD, Liu X,
Gao SY, Feng H, Wang SS, Jiang J and Ma XR: Snail and Slug
collaborate on EMT and tumor metastasis through miR-101-mediated
EZH2 axis in oral tongue squamous cell carcinoma. Oncotarget.
6:6797–6810. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ren ZH, Wu HJ, Zhang S, Wang K, Gong ZJ,
He ZJ and Peng J: A new surgical strategy for treatment of tongue
squamous cell carcinoma based on anatomic study with preliminary
clinical evaluation. J Craniomaxillofac Surg. 43:1577–1582. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Keski-Säntti H, Atula T, Törnwall J,
Koivunen P and Mäkitie A: Elective neck treatment versus
observation in patients with T1/T2 N0 squamous cell carcinoma of
oral tongue. Oral Oncol. 42:96–101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Umeda M, Komatsubara H, Ojima Y,
Minamikawa T, Shibuya Y, Yokoo S, Ishii J and Komori T: A
comparison of brachytherapy and surgery for the treatment of stage
I–II squamous cell carcinoma of the tongue. Int J Oral Maxillofac
Surg. 34:739–744. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Z, Li Y, Kong D and Sarkar FH: The
role of Notch signaling pathway in epithelial-mesenchymal
transition (EMT) during development and tumor aggressiveness. Curr
Drug Targets. 11:745–751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
de Ridder M, Verovski VN, van den Berge
DL, Sermeus AB, Monsaert C, Wauters N and Storme GA: Lipid a
radiosensitizes hypoxic EMT-6 tumor cells: Role of the NF-kappaB
signaling pathway. Int J Radiat Oncol Biol Phys. 57:779–786. 2003.
View Article : Google Scholar : PubMed/NCBI
|
